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Supplementary Methods
Methodology for the synthesis of Fmoc-L-Lys(Pac)-OH for peptide synthesis
We have modified a previously published method (1) for preparation of Fmoc-L-Lys(Pac)-OH.
The modified method is shown in the Scheme. hours at rt (60 % over two steps); (e) Fmoc-OSu, NaHCO 3 water, dioxane, 0 °C 1 hour then rt overnight (73 %).
Fmoc-L-Lys(Pac)-OH (2)
Water (15 mL) and hydrochloric acid (11 M, 40 mL) were added to a solution of Fmoc-LLys(Boc)-OH 1 (26.2 g, 55.96 mmol) (2) in 150 mL of dioxane. The reaction mixture was stirred for 1 d. TLC analysis revealed complete Boc-deprotection of starting compound 1. Then, 100 mL of water was added to the reaction mixture, followed by a careful addition of NaHCO 3 (56.4 g, 672 mmol, 12
equiv.) in small portions under intensive stirring. Phenylacetyl chloride (14.8 ml mL, 112 mmol, 2 equiv.) was then added slowly by a syringe and the reaction mixture was stirred overnight at rt. Then, citric acid (64.5 g, 335.8 mmol, 6 equiv.) was added in small portions under intensive stirring and the acidified mixture (pH ~ 3) was partitioned between ethyl acetate (400 mL) and water (400 mL). The aqueous phase was washed with ethylacetate (3 x 200 mL) and combined organic layers were washed with 200 ml water, brine (3 x 200 mL), dried over Na 2 SO 4 , filtered and evaporated in vacuo. The crude product was dissolved in boiling EtOAc and purified by crystallization at -20 °C overnight. The product was filtered, washed with 100 mL of chilled (-10 °C) EtOAc and dried in vacuo. Alternatively, the product can be purified by flash chromatography on silica, using elution with a linear gradient of ethyl acetate-acetone-methanol-water 4 : 1 Alternatively, L-Lys(Pac)-OH 4 (4.6 g; 17.4 mmol) was placed in a 250 ml round-bottom flask, equipped with a magnetic spin bar and suspended and sonicated in a solution of NaHCO 3 (2.9 g ; 34.8 mmol) in 100 ml of water. The flask was immersed in an ice-cooling bath, and Fmoc-OSu (5.9 g; 17.4 mmol) in 100 ml of dioxane was added dropwise under stirring during a period of 10 min. When the addition of Fmoc-OSu was complete, the reaction mixture (white emulsion) was allowed to react for one hour at 0 °C and then 3 days at room temperature. Then, the flask was again cooled in an ice bath and concentrated HCl was carefully added dropwise until pH ~ 1 was reached. The reaction mixture was partitioned between 200 ml of water and 3 x 100 ml of ethyl acetate; combined organic layers were washed 1 x 50 ml water, 2 x 50 brine and dried with Na 2 SO 4 . The mixture was directly injected into the HPLC system (Analytical-preparative radio-HPLC, pump Waters 600, UV detector Waters 2487, radio chromatogram detector Ramona (Raytest, Germany).
The desired mono-iodinated product was separated from the unmodified and over-iodinated analog on Mass spectrometry analysis of iodinated fractions was performed using UltrafleXtreme™ MALDI-TOF/TOF (Bruker Daltonics). At first, the extent of iodination was determined (analysis conditions: sample diluted in 50 % acetonitrile with 0.1 % TFA was applied on DHB matrix and analyzed in linear mode, instrumental setting tuned to 5 -20 kDa). Then, cysteines were reduced and alkylated, using iodoacetamide to distinguish among iodination on A chain or B chain (analysis conditions: sample diluted in 50 % acetonitrile with 0.1 % TFA was applied on DHB matrix and analyzed in reflectron mode, instrumental setting tuned to 2 -6 kDa). The position of Tyr residue modified by iodine was revealed after digestion with trypsine through LC-MS/MS peptide analysis on ULTIMATE 3000 RSLCnano (Dionex, Thermo Scientific) coupled to TripleTOF TM 5600 (SCIEX).
The extent of iodination in a specific position in the three fractions containing iodinated Tyr residues was approximated by comparing the area of peaks corresponding to peptides containing TyrB16, TyrB26 and TyrB32 and their iodinated counterparts.
Receptor-binding Studies
Human IM-9 lymphocytes (containing IR-A) and IGF-1R null mouse embryonic fibroblasts, stably transfected with either human IR-B or human IGF-1R, were employed for whole cell receptorbinding assay as described previously (3) (4) (5) . For dose-response curves for accelerated dissociation the cells (3 x 10 7 /mL) in HEPES binding buffer were preincubated with the radio-labeled ligand (about 2500 Ci/mmol, 150,000 cpm/mL, about 0.03 nM) for 2.5 hours at 15°C. After the preincubation, the suspension was centrifuged at 1000 x g, 4°C
for 5 min and the supernatant containing the unbound radioactivity was discarded. The pellet was resuspended in the initial volume of buffer. Duplicate aliquots were diluted 40 times and incubated in increasing amounts of cold ligand (0.001 nM -10 M) for 30 min at 15°C. A duplicate aliquot where no cold ligand was added was incubated at the same conditions. After the incubation the aliquots were centrifuged at 600 x g, 4°C for 5 min, supernatant was discarded and the remaining radioactivity was counted using the Gamma Counter Wizard 1470 (Perkin Elmer). Non-specific binding was substracted from the obtained values. IM-9 cells were used for IR-A measurements and CHO-R+ cells were used for IGF-1R. To fit the curves we used functions predefined in GraphPad Prism 5 software. IR-A curves were fitted using non-linear regression, dose-response special for bell-shaped. IGF-1R curves were fitted using non-linear regression, competitive binding fitting log IC50.
For association kinetics, the cells (10 7 /mL) in HEPES binding buffer were incubated with the radio-labeled ligand (about 2500 Ci/mmol, 150,000 cpm/mL, about 0.03 nM) at 15°C. At specific time points, duplicate aliquots of 200 L were centrifuged at 15,000 x g, 4°C for 10 minutes in microfuge tubes containing 200 L of pre-cooled HEPES binding buffer. The supernatant was discarded and the remaining radioactivity in the pellet was counted using the Gamma Counter Wizard 1470 (Perkin Elmer). ). Non-specific binding was substracted from the obtained values. Duplicate aliquots of 200 L of non-centrifuged cells were counted as total. IM-9 and CHO-R+ cells were used as described for dose-response curves for accelerated dissociation. To fit the curves we used a function for association kinetics -one concentration of hot predefined in the GraphPad Prism 5 software.
For dissociation kinetics, the cells (3x10 7 /mL) in HEPES binding buffer were preincubated with the radio-labeled ligand (about 2500 Ci/mmol, 150,000 cpm/mL, about 0.03 nM) at 15°C for 2.5 hours in the case of insulin and analog binding to IR-A. In the case of IGF-1 binding to IR-A, the preincubation lasted 4 hours. The period was 2.5 hours for analog and IGF-1 binding to IGF-1R, and 7
hours in the case of insulin binding to IGF-1R. The preincubation duration was estimated based on association kinetics (time after reaching the steady state). After the preincubation, the cell suspension was centrifuged at 1000 x g. 4°C for 5 min. The supernatant was discarded and the pellet resuspended in the initial volume of buffer. Duplicate aliquots were diluted 40 times in presence or absence of cold ligand and incubated at 15°C. The concentrations of cold ligand used were 170 nM for all the experiments, except for insulin on IGF-1R, where a 17 μM solution of insulin was used. At specific time points, duplicate aliquots were centrifuged at 600 x g, 4°C for 5 min. The supernatant was discarded and the remaining radioactivity in the pellet was counted using the Gamma Counter Wizard 1470 (Perkin Elmer). IM-9 and CHO-R+ cells were used as described for dose-response curves for accelerated dissociation. To fit the curves we used a model for dissociation -one phase exponencial decay predefined in the GraphPad Prism 5 software.
Receptor Phosphorylation Assay
Cell stimulation and detection of receptor phosphorylation were performed as described insulin.
Ligand-dose response IGF-1R autophosphorylation levels for selected analogs were determined, using In-Cell Western assay adapted for chemiluminiscence as described in (6 Then plates were thoroughly washed with TBS and incubated with peroxidase-labeled anti-rabbit secondary antibody (Sigma) for 1 hour at room temperature, and washed again. SuperSignal West Femto maximum sensitivity substrate was added to each well and chemiluminiscence was detected using the ChemiDoc MP Imaging System after 5 min. The ligands were tested in triplicates on each plate and intensities after subtraction of background (wells with no ligand) were related to the average intensity detected in wells stimulated with 10 nM IGF-1 on the particular plate (i.e. average intensity detected in 3 wells per plate stimulated with 10 nM IGF-1). Experiments were repeated four times. Log(agonist) vs.
response curve fitting of data was carried out with GraphPad Prism5 software. Tables   Table S1: Source data for calculation of kinetics coefficient ratios. Table 1. b Dissociation rate at maximal acceleration was measured as the rate of dissociation of 125 I-labeled ligand in the presence of cold ligand. Ratios of dissociation factors for site 1 (d1) were calculated from these values.
Supplementary
c Dissociation rate was measured as the rate of dissociation of 125 I-labeled ligand without the presence of cold ligand (measured), or it was derived from a constant calculated for the first ligand dissociation in the model for negative cooperativity (derived) (7) . The (derived) constants were adjusted to the respective analog according to the found (d1) ratios.
d Association rates were obtained after fitting the experimental data to association kinetics in GraphPad Prism 5 software, using both the (measured) and the (derived) values of dissociation constants c . 
